Perimenopausal Depression

4

Review clinical trials related to Perimenopausal Depression. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Multidimensional Determinants of Functional Health In Women Aged 45-60

The goal of this observational study is to learn about the multidimensional determinants of functional health in women aged 45 to 60 years. The study will focus on the role of muscle strength, bone mineral density, body composition, physical activity, sleep quality, depressive symptoms, and menopause-related symptoms in functional health. The main questions it aims to answer are: 1. Does muscle strength contribute to functional health in women aged 45 to 60 years? 2. Does bone mineral density contribute to functional health in women aged 45 to 60 years? 3. How are physical activity, sleep quality, depressive symptoms, body composition, and menopause-related quality of life associated with functional health? Participants will: * Undergo handgrip strength measurement * Perform a 30-second chair stand test * Undergo bone mineral density and body composition assessment * Complete questionnaires about physical activity, sleep quality, depressive symptoms, menopausal symptoms, and quality of life * Provide demographic and clinical information

Participants needed: 200
Trial details
Age: 45-60Biological sex: FemaleType: ObservationalSponsor: Kartal City HospitalUpdated: Jun 25, 2026Duration: 1 Day
Eligibility criteria

Women aged 45 to 60 years [+3]

Acute systemic illness [+3]

Status: Not yet recruiting

Meleis' Transition Theory-Based Education and Counseling Program in Menopausal Women

This randomized controlled trial aims to evaluate the effectiveness of a Meleis' Transition Theory-based education and counseling program on menopausal symptoms, perimenopausal depression, and menopause-specific quality of life among naturally menopausal women aged 45 to 55 years. Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive a structured four-week education and counseling program based on Meleis' Transition Theory, supported by a secure online messaging group and follow-up counseling sessions. The control group will receive routine care and standard information during the study period and will be offered a one-day educational session after completion of the final assessment. The outcomes will be measured at baseline and Week 16 using the Menopause Rating Scale, the Perimenopausal Depression Scale, and the Menopause-Specific Quality of Life Questionnaire-II.

Participants needed: 114
Trial details
Age: 45-55Biological sex: FemaleType: InterventionalSponsor: Ankara Medipol UniversityUpdated: Jun 22, 2026Locations: 1
Eligibility criteria

Female participants aged 45 to 55 years [+10]

Failure to continue participation in the study [+4]

Status: Not yet recruiting

The Effect of Cold Packs on Hot Flushes and Depression in Women Going Through the Climacteric Period

This study is planned as a pre-post test, randomised controlled, experimental trial designed to determine the effect of applying a cold gel pack to the Sanyinjiao (SP6) and Hegu (Large Intestinal 4 (LI4)) acupoints on hot flushes and depression in women during the climacteric period.

Participants needed: 80
Trial details
Biological sex: FemaleType: InterventionalSponsor: Rabia AtillaUpdated: Apr 21, 2026Locations: 1
Eligibility criteria

In the perimenopausal phase (no menstruation for 3-11 months or an increase in i... [+3]

Women who have entered menopause following surgery, [+9]

Status: Recruiting

A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

The goal of this observational study is to investigate the accuracy of the device in characterizing perimenopausal and menopausal symptoms including vasomotor symptoms, anxiety, sleep quality compared to self-reported symptoms via an app. The main question it aims to answer is: What is the accuracy of the developed algorithm from the investigational device compared to daily self-report via an app in characterizing perimenopausal symptoms? Participants will be asked to wear IndentifyHer's wearable non-invasive sensor and complete a daily electronic diary and questionnaires on stress, anxiety, and sleep.

Participants needed: 110
Trial details
Age: 35-55Biological sex: FemaleType: ObservationalSponsor: IdentifyHer LimitedUpdated: Sep 18, 2025Locations: 1
Eligibility criteria

Females between 35-55 years of age, inclusive [+9]

Allergy or sensitivity to adhesive used for wearing the investigational device [+11]